Concepedia

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer

Yukio Iwashita, Kouichirou Tahara, Shigeru Goto, Atsushi Sasaki, Seiichiro Kai, Masataka Seike, Chao‐Long Chen, Katsunori Kawano, Seigo Kitano

Cancer Immunology Immunotherapy · 2003 · 124 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Federica Sallusto, Antonio Lanzavecchia · The Journal of Experimental Medicine · 1994 · 5.2K citations · Full text

, , +17

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

, , +14

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

Frank J. Hsu, Claudia Benike, Francesco Fagnoni et al. · Nature Medicine · 1996 · 1.8K citations

, , +16

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Tadatoshi Takayama, Teruaki Sekine, Masatoshi Makuuchi et al. · The Lancet · 2000 · 848 citations

, , +10

Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules

Zu T. Shen, G Reznikoff, Glenn Dranoff et al. · The Journal of Immunology · 1997 · 838 citations · Full text

, , +14